nanoparticules
Value-Added Nanotechnology
Pioneer company of nanohybrids for industrial applications
Nano-H, founded in December 2004 by Lyon university researchers, specializes in developing innovative technologies for new materials based on hybrid nanoparticles. The company focuses on functional nanomaterials for optics and tracers, nanomaterials for biological applications, particularly nanodrugs, and chitosan-based hydrogels for biomedical use. Additionally, Nano-H leverages AI to analyze multimineral profiles for innovative diagnostic and prognostic purposes.
Nano-H developed the first hybrid organic/inorganic theranostic drug, AGuIX
PUBLICATIONS
Nano-H has collaborated with numerous companies and academic laboratories on collaborative projects, participating in 17 ANR, European, or other projects as a co-developer or contractor. Its teams and founding members have contributed to over a hundred scientific publications related to Nano-Hybrids.
ANALYTICAL AND MEDICAL STRATEGY
We offer customized research projects for the academic and industrial sectors. This activity is based on Nano-H's expertise and its ability to adapt its materials to the applications of its customers and partners.
Nano-h is also part of the IMITATE ANR :
Integrated Microsystems for In silico Modeling and in vitro assessment of nanoparticle TrAnsport & radioTherapy Efficacy
